Диссертация (1145685), страница 25
Текст из файла (страница 25)
The IL-1 family: regulators of immunity / J. E. Sims, D. E. Smith // Nat. Rev. Immunol.– 2010. – Т. 10 – № 2 – 89–102 p.123. Smith D.E. Four new members expand the interleukin-1 superfamily / D. E. Smith, B. R.Renshaw, R. R. Ketchem, M. Kubin, K. E. Garka, J. E. Sims // J.
Biol. Chem. – 2000. – Т. 275 – № 2– 1169–1175 p.124. Solbiati J. Processing of the N termini of nascent polypeptide chains requires deformylation priorto methionine removal / J. Solbiati, A. Chapman-Smith, J. L. Miller, C. G. Miller, J. E. Cronan // J.Mol. Biol. – 1999. – Т. 290 – № 3 – 607–614 p.125. Sugiura K. IL36RN mutations underlie impetigo herpetiformis / K.
Sugiura, N. Oiso, S. Iinuma,H. Matsuda, M. Minami-Hori, A. Ishida-Yamamoto, A. Kawada, H. Iizuka, M. Akiyama // J. Invest.Dermatol. – 2014. – Т. 134 – № 9 – 2472–2474 p.140126. Sugiura K. A novel IL36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanesepatient with adult-onset generalized pustular psoriasis / K. Sugiura, T. Takeichi, M. Kono, Y. Ogawa,Y. Shimoyama, Y. Muro, M.
Akiyama // Br. J. Dermatol. – 2012. – Т. 167 – № 3 – 699–701 p.127. Thomas C. Structure of the activating IL-1 receptor signaling complex / C. Thomas, J. F. Bazan,K. C. Garcia // Nat. Struct. Mol. Biol. – 2012. – Т. 19 – № 4 – 455–457 p.128. Thomi R. Increased expression of the interleukin-36 cytokines in lesions of hidradenitissuppurativa / R.
Thomi, M. Kakeda, N. Yawalkar, C. Schlapbach, R. E. Hunger // J. Eur. Acad.Dermatol. Venereol. JEADV – 2017.129. Thorlakson H.H. Lysophosphatidic acid induces expression of genes in human oral keratinocytesinvolved in wound healing / H. H. Thorlakson, S. A. Engen, O. Schreurs, K. Schenck, I. J. S. Blix //Arch. Oral Biol. – 2017.
– Т. 80 – 153–159 p.130. Tomuschat C. Altered expression of IL36γ and IL36 receptor (IL1RL2) in the colon of patientswith Hirschsprung’s disease / C. Tomuschat, A. M. O’Donnell, D. Coyle, P. Puri // Pediatr. Surg. Int. –2017. – Т. 33 – № 2 – 181–186 p.131. Torsekar R. Topical Therapies in Psoriasis / R. Torsekar, M. M. Gautam // Indian Dermatol.Online J. – 2017. – Т. 8 – № 4 – 235–245 p.132. Tortola L. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk / L.Tortola, E.
Rosenwald, B. Abel, H. Blumberg, M. Schäfer, A. J. Coyle, J.-C. Renauld, S. Werner, J.Kisielow, M. Kopf // J. Clin. Invest. – 2012. – Т. 122 – № 11 – 3965–3976 p.133. Towne J.E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP toactivate the pathway leading to NF-kappaB and MAPKs / J. E. Towne, K. E. Garka, B. R. Renshaw,G.
D. Virca, J. E. Sims // J. Biol. Chem. – 2004. – Т. 279 – № 14 – 13677–13688 p.134. Towne J.E. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, andIL-36γ) or antagonist (IL-36Ra) activity / J. E. Towne, B. R. Renshaw, J. Douangpanya, B. P. Lipsky,M. Shen, C. A. Gabel, J. E. Sims // J.
Biol. Chem. – 2011. – Т. 286 – № 49 – 42594–42602 p.135. Tsutsui H. Interleukin-1 Family Cytokines in Liver Diseases / H. Tsutsui, X. Cai, S. Hayashi //Mediators Inflamm. – 2015. – Т. 2015 – 630265 p.141136. Tsutsumi N. The structural basis for receptor recognition of human interleukin-18 / N. Tsutsumi,T. Kimura, K.
Arita, M. Ariyoshi, H. Ohnishi, T. Yamamoto, X. Zuo, K. Maenaka, E. Y. Park, N.Kondo, M. Shirakawa, H. Tochio, Z. Kato // Nat. Commun. – 2014. – Т. 5 – 5340 p.137. Veerdonk F.L. van de IL-38 binds to the IL-36 receptor and has biological effects on immunecells similar to IL-36 receptor antagonist / F. L. van de Veerdonk, A. K.
Stoeckman, G. Wu, A. N.Boeckermann, T. Azam, M. G. Netea, L. A. B. Joosten, J. W. M. van der Meer, R. Hao, V. Kalabokis,C. A. Dinarello // Proc. Natl. Acad. Sci. U. S. A. – 2012. – Т. 109 – № 8 – 3001–3005 p.138. Vigne S. IL-36R ligands are potent regulators of dendritic and T cells / S. Vigne, G. Palmer, C.Lamacchia, P.
Martin, D. Talabot-Ayer, E. Rodriguez, F. Ronchi, F. Sallusto, H. Dinh, J. E. Sims, C.Gabay // Blood – 2011. – Т. 118 – № 22 – 5813–5823 p.139. Vigne S. IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1polarization of naive CD4+ T cells / S. Vigne, G. Palmer, P. Martin, C. Lamacchia, D. Strebel, E.Rodriguez, M. L. Olleros, D.
Vesin, I. Garcia, F. Ronchi, F. Sallusto, J. E. Sims, C. Gabay // Blood –2012. – Т. 120 – № 17 – 3478–3487 p.140. Vlasak J. Identification and characterization of asparagine deamidation in the light chain CDR1 ofa humanized IgG1 antibody / J. Vlasak, M. C. Bussat, S.
Wang, E. Wagner-Rousset, M. Schaefer, C.Klinguer-Hamour, M. Kirchmeier, N. Corvaïa, R. Ionescu, A. Beck // Anal. Biochem. – 2009. – Т. 392– № 2 – 145–154 p.141. Wakankar A.A. Formulation considerations for proteins susceptible to asparagine deamidationand aspartate isomerization / A. A. Wakankar, R. T. Borchardt // J. Pharm. Sci. – 2006. – Т. 95 – № 11– 2321–2336 p.142. Wang D. Structural insights into the assembly and activation of IL-1β with its receptors / D.Wang, S. Zhang, L. Li, X. Liu, K. Mei, X. Wang // Nat. Immunol. – 2010. – Т. 11 – № 10 – 905–911p.143. Wang J.
A systematic review on the efficacy and safety of Infliximab in patients with psoriasis /J. Wang, Q. Zhan, L. Zhang // Hum. Vaccines Immunother. – 2016. – Т. 12 – № 2 – 431–437 p.144. Wang W. Dual effects of Tween 80 on protein stability / W. Wang, Y. J. Wang, D. Q. Wang //Int. J. Pharm. – 2008. – Т. 347 – № 1–2 – 31–38 p.142145. Weber A. Interleukin-1 (IL-1) pathway / A. Weber, P. Wasiliew, M. Kracht // Sci.
Signal. – 2010.– Т. 3 – № 105 – cm1 p.146. Wetzel R. Assignment of the disulphide bonds of leukocyte interferon / R. Wetzel // Nature –1981. – Т. 289 – № 5798 – 606–607 p.147. Winter G. Formulation Strategies for Recombinant Protein and Related Biotech Drugs / под ред.O. Kayser, H. Warzecha. Wiley-VCH Verlag GmbH & Co. KGaA, 2012. – 235–256 p.148. Yan R. Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematicreview / R. Yan, S. Jiang, Y. Wu, X.-H. Gao, H.-D. Chen // Indian J. Dermatol. Venereol. Leprol.
–2016. – Т. 82 – № 2 – 135–144 p.149. Yao J. Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaBactivation pathways bifurcate at IL-1 receptor-associated kinase modification / J. Yao, T. W. Kim, J.Qin, Z. Jiang, Y. Qian, H.
Xiao, Y. Lu, W. Qian, M. F. Gulen, N. Sizemore, J. DiDonato, S. Sato, S.Akira, B. Su, X. Li // J. Biol. Chem. – 2007. – Т. 282 – № 9 – 6075–6089 p.150. Yi G. Structural and functional attributes of the Interleukin-36 receptor / G. Yi, J. A. Ybe, S. S.Saha, G. Caviness, E. Raymond, R. Ganesan, M. L. Mbow, C. C. Kao // J.
Biol. Chem. – 2016.151. Yordanova D. Molecular Modeling of Triton X Micelles: Force Field Parameters, Self-Assembly,and Partition Equilibria / D. Yordanova, I. Smirnova, S. Jakobtorweihen // J. Chem. Theory Comput. –2015. – Т. 11 – № 5 – 2329–2340 p.152. Yuan X. Role of IL-38 and Its Related Cytokines in Inflammation// Mediators of Inflammation[Электронный ресурс]. URL: https://www.hindawi.com/journals/mi/2015/807976/ (дата обращения:31.07.2017).153. Zelickson B.D. Generalized pustular psoriasis. A review of 63 cases / B.
D. Zelickson, S. A.Muller // Arch. Dermatol. – 1991. – Т. 127 – № 9 – 1339–1345 p.154. Zimmerman T. Simultaneous metal chelate affinity purification and endotoxin clearance ofrecombinant antibody fragments / T. Zimmerman, C. Petit Frère, M. Satzger, M. Raba, M. Weisbach,K. Döhn, A. Popp, M. Donzeau // J. Immunol. Methods – 2006. – Т. 314 – № 1–2 – 67–73 p.143155. Bachmann M. IL-36γ/IL-1F9, an Innate T-bet Target in Myeloid Cells / M. Bachmann, P.Scheiermann, L.
Härdle, J. Pfeilschifter, H. Mühl // J. Biol. Chem. – 2012. – Т. 287 – № 50 – 41684–41696 p.156. Bowers P. Antibodies directed against interleukin 36 receptor (il-36r) / P. Bowers, A. J.Mcknight, D. J. King, M. Londei – 2016.157. Bufler P. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18activity / P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
